Skip to main content
Figure 5 | Malaria Journal

Figure 5

From: A mathematical model of the impact of present and future malaria vaccines

Figure 5

Reduction in clinical incidence by age after child-targeted PEV campaign. The daily clinical incidence grouped by age — under 5 years (upper panel), 5 to 10 years (middle panel), over 10 years (lower panel) — in a scenario with 40% population-wide ITN coverage (black lines) compared to scenarios that additionally include a mass-vaccination of under-5 year-olds followed by routine vaccination of newborns with a 50% (blue lines) or 90% (red lines) efficacy PEV at 80% coverage. Daily incidence rates are presented as the running average over a one-month window.

Back to article page